betaxolol has been researched along with practolol in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (50.00) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ball, JB; Iakovidis, D; Jackman, G; Louis, WJ; Nero, TL; Tung, L | 1 |
| Binet, JL; Cavero, IG; Lefèvre-Borg, F; Manoury, PM; Rousseau, J | 1 |
| Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
| Aué, GH; Bultsma, T; IJzerman, AP; Linschoten, MR; Timmerman, H | 1 |
| Baldwin, JJ; Denny, GH; Freedman, MB; Gross, DM; Hirschmann, R; Ponticello, GS; Sweet, CS | 1 |
| Iakovidis, D; Jackman, GP; Louis, SN; Louis, WJ; Nero, TL | 1 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Brunton, LL; Buxton, IL | 1 |
| Gomeni, R; Kilborn, JR; Morselli, PL; Saunders, J; Sönksen, PH | 1 |
| Curtis-Prior, PB; Tan, S | 1 |
| Engel, G | 1 |
| Abuin, L; Cotecchia, S; Lattion, A; Nenniger-Tosato, M | 1 |
1 review(s) available for betaxolol and practolol
| Article | Year |
|---|---|
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
15 other study(ies) available for betaxolol and practolol
| Article | Year |
|---|---|
Computer-aided mapping of the beta-adrenoceptor. 1. Explanation for effect of para substitution on blocking activity at the beta-1-adrenoceptor.
Topics: Adrenergic beta-Antagonists; Computer Simulation; Propanolamines; Stereoisomerism; Structure-Activity Relationship | 1992 |
Synthesis of a series of compounds related to betaxolol, a new beta 1-adrenoceptor antagonist with a pharmacological and pharmacokinetic profile optimized for the treatment of chronic cardiovascular diseases.
Topics: Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Antihypertensive Agents; Betaxolol; Biotransformation; Cardiovascular Diseases; Chronic Disease; Female; Guinea Pigs; In Vitro Techniques; Kinetics; Male; Propanolamines; Rana esculenta; Rats; Structure-Activity Relationship | 1987 |
Quantitative evaluation of the beta 2-adrenoceptor affinity of phenoxypropanolamines and phenylethanolamines.
Topics: Animals; Cattle; Chemical Phenomena; Chemistry; Dihydroalprenolol; Ethanolamines; Guanylyl Imidodiphosphate; Hydrogen-Ion Concentration; Muscles; Propanolamines; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1985 |
Beta 1-selective adrenoceptor antagonists: examples of the 2-[4-[3-(substituted-amino)-2-hydroxypropoxy]phenyl]imidazole class.
Topics: Adrenergic alpha-Agonists; Animals; Female; Guinea Pigs; Heart; Imidazoles; Indicators and Reagents; Isoproterenol; Magnetic Resonance Spectroscopy; Receptors, Adrenergic; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1983 |
LK 204-545, a highly selective beta1-adrenoceptor antagonist at human beta-adrenoceptors.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; CHO Cells; Cricetinae; Cyclopropanes; Female; Humans; Imidazoles; In Vitro Techniques; Ligands; Phenoxypropanolamines; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Trachea; Urea | 1999 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Direct analysis of beta-adrenergic receptor subtypes on intact adult ventricular myocytes of the rat.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Betaxolol; Binding Sites; Cells, Cultured; Ethanolamines; Heart; Iodine Radioisotopes; Iodocyanopindolol; Male; Myocardium; Pindolol; Practolol; Propanolamines; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta | 1985 |
A comparison between propranolol, practolol and betaxolol (SL75212) on the circulatory and metabolic responses to insulin-induced hypoglycaemia.
Topics: Adrenergic beta-Antagonists; Adult; Betaxolol; Blood Glucose; Blood Pressure; Fatty Acids, Nonesterified; Glycerol; Growth Hormone; Heart Rate; Humans; Hypoglycemia; Insulin; Male; Practolol; Propanolamines; Propranolol | 1981 |
Characterization of the beta-adrenoceptor of the adipose cell of the rat.
Topics: Adipose Tissue; Adrenergic beta-Agonists; Albuterol; Animals; Betaxolol; Dose-Response Relationship, Drug; Isoproterenol; Lipolysis; Norepinephrine; Practolol; Prenalterol; Propanolamines; Propranolol; Rats; Receptors, Adrenergic, beta | 1983 |
Subclasses of beta-adrenoceptors--a quantitative estimation of beta 1- and beta 2- adrenoceptors in guinea pig and human lung.
Topics: Aged; Animals; Atenolol; Betaxolol; Cell Membrane; Guinea Pigs; Humans; Iodocyanopindolol; Lung; Metoprolol; Middle Aged; Models, Biological; Pindolol; Practolol; Propanolamines; Receptors, Adrenergic; Receptors, Adrenergic, beta | 1981 |
Constitutively active mutants of the beta1-adrenergic receptor.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Amino Acid Substitution; Betaxolol; Carbazoles; Carvedilol; Cell Line; Cyclic AMP; Epinephrine; Humans; Imidazoles; Isoproterenol; Labetalol; Point Mutation; Practolol; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Recombinant Proteins; Timolol | 1999 |